Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Tamura

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Modern Rheumatology|March 7, 2025
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: final analysis of an all-case post-marketing surveillance studyMasataka Kuwana, Naonobu Sugiyama, Shigeki Momohara, et al.
Pathology, Research and Practice|March 20, 2025
Artificial intelligence challenge of discriminating cutaneous arteritis and polyarteritis nodosa based on hematoxylin-and-eosin images of skin biopsy specimensWataru Kashiwa, Kenji Hirata, Hiroki Endo, et al.
Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2023
Synovial Tissue Heterogeneity in Japanese Patients With Rheumatoid Arthritis Elucidated Using a Cell-Type Deconvolution ApproachSotaro Nakajima, Haruka Tsuchiya, Mineto Ota, et al.
Arthritis Care & Research|March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritisRyoko Sakai, Yukiko Komano, Michi Tanaka, et al.
International Journal of Rheumatic Diseases|April 14, 2023
Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapyNoboru Kitamura, Hitomi Kobayashi, Yosuke Nagasawa, et al.
RMD Open|September 17, 2021
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA studyMitsumasa Kishimoto, Keisuke Ono, Sho Fukui, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Drug Discoveries & Therapeutics|April 26, 2026
Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)Toshimasa Shimizu, Shin-Ya Kawashiri, Tomohiro Koga, et al.
Modern Rheumatology|December 16, 2021
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)Naoto Tamura, Takanori Azuma, Kenta Misaki, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Modern Rheumatology|March 7, 2025
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: final analysis of an all-case post-marketing surveillance studyMasataka Kuwana, Naonobu Sugiyama, Shigeki Momohara, et al.
Pathology, Research and Practice|March 20, 2025
Artificial intelligence challenge of discriminating cutaneous arteritis and polyarteritis nodosa based on hematoxylin-and-eosin images of skin biopsy specimensWataru Kashiwa, Kenji Hirata, Hiroki Endo, et al.
Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2023
Synovial Tissue Heterogeneity in Japanese Patients With Rheumatoid Arthritis Elucidated Using a Cell-Type Deconvolution ApproachSotaro Nakajima, Haruka Tsuchiya, Mineto Ota, et al.
Arthritis Care & Research|March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritisRyoko Sakai, Yukiko Komano, Michi Tanaka, et al.
International Journal of Rheumatic Diseases|April 14, 2023
Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapyNoboru Kitamura, Hitomi Kobayashi, Yosuke Nagasawa, et al.
RMD Open|September 17, 2021
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA studyMitsumasa Kishimoto, Keisuke Ono, Sho Fukui, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Drug Discoveries & Therapeutics|April 26, 2026
Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)Toshimasa Shimizu, Shin-Ya Kawashiri, Tomohiro Koga, et al.
Modern Rheumatology|December 16, 2021
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)Naoto Tamura, Takanori Azuma, Kenta Misaki, et al.
Pageof 20